{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT03838731: Phase 2 Interventional Completed Cat Allergy
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:ebdarokimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04194775: Phase 3 Interventional Active, not recruiting Hepatocellular Carcinoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04406727: Phase 3 Interventional Not yet recruiting HIV-1 Infection
(2023)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03514121: Early Phase 1 Interventional Terminated Breast Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:luveltamab tazide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03207243: Phase 2 Interventional Completed Asthma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01802814: Phase 3 Interventional Completed Acute Lymphoblastic Leukemia (ALL)
(2014)
Source URL:
Class:
PROTEIN
